Share this story!
This newsletter is for you who are a Premium Supporter at Warp News. Feel free to share it with friends and acquaintances.
🎅 Christmas Break
Your inbox will be empty until January 9, when the next newsletter arrives.
During the same period, Warp News will publish a news story every other day, instead of daily.
Thanks for your support during 2023! Happy New Year!
Btw, check out this superb discussion between Steven Pinker and David Deutsch. Both are intellectual heroes of mine (and like all smart people they are Warp Premium Supporters.) Their discussion on AI, and especially AGI, is next level.
The Angry Optimist
Premium Supporter content
No login is required to read them.
💡 Hopescrolling: 52 fact-based optimistic news from every week in 2023
What were the biggest news stories of the year? If you look at mainstream media, except for Taylor Swift’s Eras tour, they were all disasters. But 2023 was also full of optimistic news. Not as loud, but oftentimes just as important.
📚 The Angry Optimist's book recommendations for Christmas
Four reading tips for Christmas. Everything from a history of the electronic era to the creator of Spaceballs.
Fact-based optimistic news of the week
💊 The FDA approves first CRISPR-based gene therapy drug for sickle cell disease
The approvals include the first-ever CRISPR-Cas9 based drug, Casgevy, and a gene therapy drug, Lyfgenia, marking a milestone in medical biotechnology.
👵 Surprise! Life expectancy in the U.S. is still going up (despite what you've heard)
Contrary to widespread reports, life expectancy in the United States continues to show signs of improvement.
🛰️ Starlink's space internet traffic nearly triples in 2023
With expansion to new countries, including Kenya, the Philippines, and Zambia, it has a presence in over 50 countries.
⛈️ DeepMind AI achieves precise weather predictions on desktop computers
GraphCast predicts weather up to 10 days in advance with remarkable accuracy, and uses only seconds to process the data, surpassing traditional methods.
🏆 Science Breakthrough of the Year: Obesity drugs (+ runners-up)
Obesity, a major health problem affecting about 70% of adults in the U.S. and over half in Europe, is linked to several serious diseases. Recently, a new class of drugs, GLP-1 receptor agonists, originally for diabetes, has shown significant promise in treating obesity with manageable side effects.
♻️ Cling Systems secures vital funding to propel battery circularity
Cling Systems is a Swedish startup helping companies recycle used electric car batteries. Now they've secured 1.3 million USD in funding.
🎙️ Fact-based optimism at your event?
Are you planning a conference or event and feeling too much doom and gloom? Book me, The Angry Optimist, to spread fact-based optimism and hope.
Learn more at mathiassundin.org.